Careers

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2025 HSCA National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Congressional Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2025 HSCA National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Congressional Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News

HSCA Comments on Federal Trade Commission (FTC) and Department of Health and Human Services (HHS) Joint RFI on Generic Drug Shortages

May 30, 2024 by samuelfreund Uncategorized 0 comments

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide our response to the joint RFI published by the FTC and HHS on February 15, 2024.

 

Click here to read the full response.

Prev
Next

Related Posts

2024 HSCA Pharmacy Forum Slides
February 1, 2024

This content is password protected. To view it please enter your password...

Learn more
HSCA Comments on Federal Trade Commission (FTC) and Department of Health and Human Services (HHS) Joint RFI on Generic Drug Shortages
May 30, 2024

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...

Learn more

Our Office

Healthcare Supply Chain Association
750 9th Street NW, Suite 650
Washington, DC 20001

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Statement on Recent Executive Order to Promote Domestic Production of Critical Medicines
    May 20, 2025
  • HSCA Response to the U.S. Department of Commerce’s Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients
    May 8, 2025